Physician profile
Aaron R Chambers
NPI 1649687930
$4,884.43
in general payments reported to CMS, 2019-2025
10 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,305 · 2020: $87.24 · 2021: $60.00 · 2022: $354 · 2023: $423 · 2024: $400 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,531.42 | 2019 | |
| Paragon 28, INC. | $1,222.54 | 2019 | |
| Smith+Nephew, INC. | $1,106.87 | 2019-2025 | Collagenase Santyl, Regranex, Stravix |
| Stryker Corporation | $393.97 | 2021-2025 | Ortholoc 2 Lapifuse, Na, Ortholoc 3di |
| Summit Surgical Corp. | $182.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $178.32 | 2019-2020 | |
| Wright Medical Technology, INC. | $164.45 | 2019 | |
| Osiris Therapeutics INC. | $67.41 | 2019 | |
| Nevro Corp. | $24.09 | 2021 | |
| Integra Lifesciences Corporation | $13.36 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.